Chief Financial Officer and Deputy Chief Executive Officer
Born in 1966. Joined IRRAS in 2017.
Education and relevant experience:
Mr. Alpsten received a M.Sc. degree from the Stockholm School of Economics. Fredrik Alpsten brings approximately twenty years of operational, financial, and strategic business experience as an executive in the medical technology field. Most recently, Mr. Alpsten served as Senior Vice President and CFO of Boule Diagnostics AB (Boule), a Swedish publicly-traded diagnostics company. During his time at Boule, Mr. Alpsten also served as President and CEO of Clinical Diagnostic Solutions Inc., a US subsidiary of Boule. Prior to his tenure at Boule he was President and CEO of Doxa AB, a publicly-traded medical technology company located in Sweden.
Other current assignments:
Mr. Alpsten currently serves as Chairman of the Board of Personlig Almanacka Nordic AB. He is also a board member and chairman of the audit committee of Binero Group AB (listed at Nasdaq) and board member of Pharmetheus AB.
Shareholding in IRRAS: 9,200 shares.
Holding of warrants: 200,000 warrants in program 2017/2020 and 30,000 warrants under the 2018/2022 warrant program.